Pharmaceutical news | ELSI Avocats

Filter by

Pharmaceutical law

Prohibition of patient benefits, remuneration, digital tools: what the Leem 2025 DDPs are likely to block

Leem 2025 DDP, sticking points

Pharmaceutical law

LEEM DDP 2025, what you need to know from the new updates

Deciphering LEEM's new PDDs: the ethical framework for Industry-Patient relations and patient associations

Pharmaceutical law

Contracts with influential doctors: clarifications from the CNOM

A look back at the contractual clarifications expected by the CNOM in contracts with influencer physicians.

Medical device law

Obligations of medical device (MD) distributors: clarification of their scope before the CJEU

The Advocate General of the CJEU clarifies the compliance check carried out by the DM distributor.

Pharmaceutical law

Liberal practice contracts, royalties and a framework for benefits, clarifications from the Versailles Court of Appeal ruling of February 27, 2025

The Court confirms the validity of the royalty and the legitimacy of collecting royalties in return for services.

Pharmaceutical law

Ranking of pharma firms: ELSI Avocats wins the Palmarès du Droit 2025 award

ELSI Avocats wins first place in the Palmarès du Droit 2025 in the Health category!

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Newsletter subscription

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

NEWS

Prohibition of patient benefits, remuneration, digital tools: what the Leem 2025 DDPs are likely to block

Prohibition of patient benefits, remuneration, digital tools: what the Leem 2025 DDPs are likely to block

LEEM DDP 2025, what you need to know from the new updates

Contracts with influential doctors: clarifications from the CNOM

Obligations of medical device (MD) distributors: clarification of their scope before the CJEU

Liberal practice contracts, royalties and a framework for benefits, clarifications from the Versailles Court of Appeal ruling of February 27, 2025

Ranking of pharma firms: ELSI Avocats wins the Palmarès du Droit 2025 award

Amiodarone, the Court of Cassation sanctions the lack of information in the package insert and engages the responsibility of the laboratory

Cannabis: regulation of the marketing of CBD flower before the Constitutional Council

Certificate of free sale and medical devices

Ranking of Life Sciences law firms: ELSI Avocats at the Legal Summit

Ranking of Life sciences law firms: ELSI Avocats wins 1st place in the Palmarès du Droit 2023

NEWS

Prohibition of patient benefits, remuneration, digital tools: what the Leem 2025 DDPs are likely to block

Prohibition of patient benefits, remuneration, digital tools: what the Leem 2025 DDPs are likely to block

LEEM DDP 2025, what you need to know from the new updates

Contracts with influential doctors: clarifications from the CNOM

Obligations of medical device (MD) distributors: clarification of their scope before the CJEU

Liberal practice contracts, royalties and a framework for benefits, clarifications from the Versailles Court of Appeal ruling of February 27, 2025

Ranking of pharma firms: ELSI Avocats wins the Palmarès du Droit 2025 award

Amiodarone, the Court of Cassation sanctions the lack of information in the package insert and engages the responsibility of the laboratory

Cannabis: regulation of the marketing of CBD flower before the Constitutional Council

Certificate of free sale and medical devices

Ranking of Life Sciences law firms: ELSI Avocats at the Legal Summit

Ranking of Life sciences law firms: ELSI Avocats wins 1st place in the Palmarès du Droit 2023

SUBSCRIBE TO OUR NEWSLETTER!